Home  >  Teachers  >  intra-school joint appointment  >  Lang, Hui-Chu

intra-school joint appointment

  • Lang, Hui-Chu
  • Professor
  • Full-time Professor, Institute of Hospital and Health Care Administration, National Yang Ming Chiao Tung University
  • Ph.D., Healthcare Management, The Johns Hopkins University
    Master, Public Health, National Yang-Ming Medical College
    Bachelor, Public Health, Chinese Medical University
  • Cost Effectiveness Evaluation, Hospital performance management
  • (02)2826-7015
Course
  • Position And Experience
  • Catalog Of Works

Associate Professor, Institute of Hospital and Health Care Administration, National Yang Ming University

 

Assistant Professor, Institute of Hospital and Health Care Administration, National Yang Ming University

 

Lecturer, Institute of Hospital and Health Care Administration, National Yang Ming University

  1. Chiu CM, Chen MS, Lin CS, Lin WY, Lang HC*. Evaluating the comparative efficiency of medical centers in Taiwan: a dynamic data envelopment analysis application. BMC Health Serv Res. 2022 Apr 2;22(1):435. doi: 10.1186/s12913-022-07869-8.
  2. Chiou LJ, Lang HC*. Potentially preventable hospital readmissions after patients' first stroke in Taiwan. Sci Rep. 2022 Mar 8;12(1):3743. doi: 10.1038/s41598-022-07791-3. SCI/SSCI, IF= 4.38 / Q1 (19/128). MOST 105-2410-H-010 -012 -SS2.
  3. Yang CP, Li CY, Huang WJ, Yu HL, Yang CC, Lu MC, Lang HC*, Yan YH*. Short-, Mid-, and Long-Term Associations Between PM2.5 and Stroke Incidence in Taiwan. J Occup Environ Med. 2021 Sep 1;63(9):742-751. SCI/SSCI, IF=4.4 / Q1 (39/376). MOST 105-2410-H-010 -012 -SS2
  4. Yang CP, Cheng HM, Lu MC, Lang HC*. Association between continuity of care and long-term mortality in Taiwanese first-ever stroke survivors: An 8-year cohort study. PLoS One. 2019 May 22;14(5):e0216495. SCI/SSCI, IF=3.24 / Q1 (29/128). MOST 105-2410-H-010 -012 -SS2
  5. Cheng HM, Chiou LJ, Chen TC, Sung SH, Chen CH, Lang HC*. Real-world cost- effectiveness of drug-eluting stents vs. bare-metal stents for coronary heart disease-A five-year follow-up study. Health Policy. 2019 Feb;123(2):229-234. SCI/SSCI, IF=2.98 / Q2 (48/150). NSC 101-2410-H-010
  6. Lang HC, Chen HW, Chiou TJ, Chan AL. The real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu-positive early breast cancer in Taiwan. J Med Econ. 2016 Oct;19(10):923-7. SCI/SSCI, IF=2.45 / Q2 (63/150).
  7. Chang JY, Lang HC. The Econimic Cost of Rheumatoid Arthritis in Taiwan. Value Health. 2014 Nov;17(7):A773. doi: 10.1016/j.jval.2014.08.328. Epub 2014 Oct 26. SCI/SSCI, IF=5.73 / Q1 (51/557)
  8. Shih CL, Chen CH, Sheu CF, Lang HC*, Hsieh CL. Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch model. Value Health. 2013 Jul-Aug;16(5):848-54. doi: 10.1016/j.jval.2013.05.004. Epub 2013 Jul 17. PMID: 23947980. SCI/SSCI, IF=5.73 / Q1 (51/557).
  9. Lang HC, Chang K, Ying YH. Quality of life, treatments, and patients' willingness to pay for a complete remission of cervical cancer in Taiwan. Health Econ. 2012 Oct;21(10):1217-33. SCI/SSCI, IF=3.05 / Q1 (112/557).
  10. Lang HC*. Willingness to pay for lung cancer treatment. Value Health. 2010 Sep-Oct;13(6):743-9. SCI/SSCI, IF=5.73 / Q1 (51/557).